The mission of the who international clinical trials registry platform is to ensure that a complete view of research is accessible to all those involved in health care decision making This will improve research transparency and will ultimately strengthen the validity and value of the scientific evidence base. The guidance for best practices for clinical trials has been developed in response to the 2022 world health assembly resolution (wha75.8) on strengthening clinical trials This guidance provides member states with a framework for integrating robust and ethical clinical trial practices into their national health systems, enhancing the quality, transparency, and inclusivity of trials worldwide. It aims to enhance clinical research efficiency, minimize research waste and provide guidance on sustained clinical trials that are always functional and active for endemic. Does the registry accept prospective registration of interventional clinical trials submitted by responsible registrants
Is the registry open to all prospective registrants (icmje), either internationally, or within one or more specific. In a global first, uganda’s ministry of health, the world health organization (who) and other partners today launched a first ever vaccine trial for ebola from the sudan species of the virus, and at an unprecedented speed for a randomized vaccine trial in an emergency. The purpose of this event is to engage and inform key stakeholders about the newly developed who guidance on best practices for clinical trials Through this launch, we aim to build awareness, encourage adoption, and foster collaboration among stakeholders to elevate the quality and integrity of clinical research globally. Clinical trials in children the mission of the who international clinical trials registry platform is to ensure that a complete view of research is accessible to all those involved in health care decision making Clinical evaluation is a critical step to support the approval of vaccines
The plan outlines nine priority actions to support countries and stakeholders reform and sustain clinical trial systems that are fit for purpose, inclusive and locally led.
OPEN